Diagnostic uncertainty expressed in prostate needle biopsies: A College of American Pathologists Q-probes study of 15 753 prostate needle biopsies in 332 institutions

Archives of Pathology and Laboratory Medicine

Volumn 123, Issue 8, 1999, Pages 687-692

  Novis, David A ^a   Zarbo, Richard J ^b   Valenstein, Paul A ^c  

^a Wentworth Douglass Hospital   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c Catherine MacCauley Health Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; PROSTATE SPECIFIC ANTIGEN;

CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; NEEDLE BIOPSY; PROSTATE; PROSTATE DISEASE;

ADENOCARCINOMA; BIOPSY, NEEDLE; CARCINOMA IN SITU; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; MALE; PALPATION; PATHOLOGY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; QUALITY CONTROL; RECTUM; SENSITIVITY AND SPECIFICITY;

EID: 0032815586     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Schifman RB, Howanitz PJ, Zarbo RJ. Q-Probes: a College of American Pathologists benchmarking program for quality management in pathology and laboratory medicine. Adv Pathol. 1996;9:83-120.
2. Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet. 1995;345:840-842.
3. Logan RL, Scott PJ. Uncertainty in clinical practice: implications for quality and costs in health care. Lancet. 1996;347:595-598.
4. Rainer RO, Geisinger KR. Beyond sensitivity and specificity. Am J Clin Pathol. 1995;103:541-542.
5. Skoumal SM, Florell SR, Bydalek MK, Hunter WJ. Malpractice protection: communication of diagnostic uncertainty. Diagn Cytopathol. 1996;14:383-389.